Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Volpara Health Technologies.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s Powerplays: Healthcare’s game is off, but a comeback is possible
News
ASX Small Cap Lunch Wrap: Who applied for their forklift drivers test today?
News
Here’s what CEOs are hoping to change with their New Year’s resolutions for 2022
News
Waiting for 2022? Here’s a bunch of books CEOs are reading during the holiday break
News
CEOs look ahead to three things they’re hoping for in 2022
News
CEOs look back and share their company highlights from 2021
News
CEOs look back and share the most important lesson they learnt in 2021
Health & Biotech
ScoPo’s Powerplays: Christmas rally runs out of puff, but market awaits crucial release from Neuren
Health & Biotech
Check Up: Sustainable Nutrition riding high and Singular Health branches out from… health
Health & Biotech
ASX Health: 4D Medical jumps 16pc on lungs device rollout, Proteomics up 10pc on UK deal
Health & Biotech
ScoPo’s Powerplays: Investors look to Healthcare for ESG exposure, and Volpara is the poster child
Health & Biotech
‘Delivering in all aspects’: Volpara strengthens and expands as personalised medicines sector leader
Health & Biotech
ScoPo’s Powerplays: ‘Light shining bright at the end of the tunnel’ as outlook turns positive for healthcare
Health & Biotech
Volpara reports another record-breaking quarter of strong growth, with its largest quarterly ARR performance to date
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
ScoPo’s Powerplays: All we want for Christmas is a market rally
News